Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Endocrinol., 31 October 2025

Sec. Thyroid Endocrinology

Volume 16 - 2025 | https://doi.org/10.3389/fendo.2025.1718347

Correction: Optimizing C-TIRADS for sub-centimeter thyroid nodules using machine learning–derived feature importance

Dongming GuoDongming Guo1Zhihui LinZhihui Lin1Jiajia WangJiajia Wang1Xianying LiaoXianying Liao1Haiqing HuangHaiqing Huang2Yuxia ZhaiYuxia Zhai3Zhe Chen*Zhe Chen1*
  • 1Department of Interventional Ultrasound, Cancer Hospital of Shantou University Medical College, Shantou, China
  • 2Department of Ultrasound, Cancer Hospital of Shantou University Medical College, Shantou, China
  • 3Department of Ultrasound, Second Affiliated Hospital of Shantou University Medical College, Shantou, China

A Correction on
Optimizing C-TIRADS for sub-centimeter thyroid nodules using machine learning–derived feature importance

By Guo D, Lin Z, Wang J, Liao X, Huang H, Zhai Y and Chen Z (2025) Front. Endocrinol. 16:1668347. doi: 10.3389/fendo.2025.1668347

Figures 4 and 5 were in the wrong order in the PDF and HTML versions of this paper. Figures 4 and 5 were mistakenly swapped. Figure 4 should display the risk stratification heatmap and Figure 5 should display the Decision Curve Analysis. The order has now been corrected.

Figure 4
Two heatmap charts labeled A and B show comparisons between original and modified risk levels of nodules, with corresponding color gradients from light yellow to deep red and blue. Chart A depicts counts of benign and malignant nodules with higher values concentrated in darker regions. Chart B displays similar data with different risk levels, highlighting the highest concentration in a dark blue section. Legends indicate numerical values associated with color intensity.

Figure 4. Heatmaps showing reclassification of benign and malignant nodules across C-TIRADS risk categories between the original and modified scoring systems in the primary cohort. (A) malignant nodules; (B) benign nodules.

Figure 5
A decision curve analysis chart showing standardized net benefit against threshold probability. The chart compares four lines: Original C-TIRADS (blue), Modified C-TIRADS (orange), All (gray), and None (black). Both C-TIRADS curves show superior net benefit across a range of threshold probabilities compared to All and None.

Figure 5. Decision curve analysis comparing net clinical benefit of the original and modified C-TIRADS scoring systems in the primary cohort.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: sub-centimeter thyroid nodules, C-TIRADS, machine learning, SHAP, ultrasound, risk stratification, microcarcinoma

Citation: Guo D, Lin Z, Wang J, Liao X, Huang H, Zhai Y and Chen Z (2025) Correction: Optimizing C-TIRADS for sub-centimeter thyroid nodules using machine learning–derived feature importance. Front. Endocrinol. 16:1718347. doi: 10.3389/fendo.2025.1718347

Received: 03 October 2025; Accepted: 24 October 2025;
Published: 31 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Guo, Lin, Wang, Liao, Huang, Zhai and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhe Chen, emNoZW5zZHpsQDE2My5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.